Cost analysis of antibiotics in the management of perforated or gangrenous appendicitis
Authors:
- Mark A. GillMGMark A. Gill
- Frank C. ChenellaFCFrank C. Chenella
- Peter N.R. HeseltinePHPeter N.R. Heseltine
- Maria D. ApplemanMAMaria D. Appleman
- Albert E. YellinAYAlbert E. Yellin
- Thomas V. BerneTBThomas V. Berne
- Marvin J. FeldmanMFMarvin J. Feldman
- Douglas SharonDSDouglas Sharon
- 1 February 1986
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Surgery
- Vol. 151 (2) , 200-204
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Cost Containment of Reconstituted Parenteral Antibiotics: Personnel and Supply Costs Associated with Preparation, Dispensing, and AdministrationClinical Infectious Diseases, 1984
- Economic Analysis of a New Drug: Potential Savings in Hospital Operating Costs from the Use of a Once-Daily Regimen of a Parenteral CephalosporinClinical Infectious Diseases, 1984
- New Drugs and Clinical Economics: Analysis of Cost Effectiveness in the Assessment of Pharmaceutical InnovationsClinical Infectious Diseases, 1984
- Risk Factors for Nephrotoxicity in Patients Treated with AminoglycosidesAnnals of Internal Medicine, 1984
- Perforated and Gangrenous Appendicitis: An Analysis of Antibiotic FailuresThe Journal of Infectious Diseases, 1983
- Antibiotic management of surgically treated gangrenous or perforated appendicitisThe American Journal of Surgery, 1982
- Prophylactic and Preventive Antibiotic Therapy Timing, Duration and EconomicsAnnals of Surgery, 1979